These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 3139763

  • 1. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR, Webb AC, Sitrin RG.
    J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763
    [Abstract] [Full Text] [Related]

  • 2. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ, Sitrin RG.
    J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 01; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 4. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
    Kole KL, Gyetko MR, Simpson RU, Sitrin RG.
    Biochem Pharmacol; 1991 Feb 15; 41(4):585-91. PubMed ID: 1900005
    [Abstract] [Full Text] [Related]

  • 5. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA, Medcalf RL, Kruithof EK.
    Endocrinology; 1993 Oct 15; 133(4):1724-30. PubMed ID: 8404615
    [Abstract] [Full Text] [Related]

  • 6. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J, Delarue F, Peraldi MN, Sraer JD, Rondeau E.
    Lab Invest; 1994 Dec 15; 71(6):828-37. PubMed ID: 7807964
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y, Tazawa S, Ishikawa T, Niiya K, Sakuragawa N.
    Thromb Haemost; 1995 Aug 15; 74(2):704-10. PubMed ID: 8585010
    [Abstract] [Full Text] [Related]

  • 8. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC, Quax PH, Löwik CW, Verheijen JH.
    J Bone Miner Res; 1995 Sep 15; 10(9):1374-84. PubMed ID: 7502710
    [Abstract] [Full Text] [Related]

  • 9. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb 15; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 10. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
    Michel JB, Quertermous T.
    J Immunol; 1989 Aug 01; 143(3):890-5. PubMed ID: 2501387
    [Abstract] [Full Text] [Related]

  • 11. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
    Gyetko MR, Shollenberger SB, Sitrin RG.
    J Leukoc Biol; 1992 Mar 01; 51(3):256-63. PubMed ID: 1311745
    [Abstract] [Full Text] [Related]

  • 12. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 01; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 13. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 14. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
    Tranque P, Robbins R, Naftolin F, Andrade-Gordon P.
    Glia; 1992 Aug 01; 6(3):163-71. PubMed ID: 1335967
    [Abstract] [Full Text] [Related]

  • 15. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C, Kruithof EK, Schleuning WD.
    J Cell Biol; 1987 Mar 01; 104(3):705-12. PubMed ID: 3102504
    [Abstract] [Full Text] [Related]

  • 16. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured monkey Sertoli cells.
    Liu YX, Liu K, Zhou HM, Du Q, Hu ZY, Zou RJ.
    Hum Reprod; 1995 Mar 01; 10(3):719-27. PubMed ID: 7540182
    [Abstract] [Full Text] [Related]

  • 17. Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity.
    Manchanda N, Schwartz BS.
    J Immunol; 1990 Dec 15; 145(12):4174-80. PubMed ID: 2258614
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S, Allan EH, Yee JA, Gelehrter TD, Martin TJ.
    J Cell Physiol; 1992 Aug 15; 152(2):346-55. PubMed ID: 1322417
    [Abstract] [Full Text] [Related]

  • 19. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
    Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP.
    J Rheumatol Suppl; 1991 Feb 15; 27():80-4. PubMed ID: 1851231
    [Abstract] [Full Text] [Related]

  • 20. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
    Niiya K, Sakuragawa N.
    Nihon Rinsho; 1992 Feb 15; 50(2):325-9. PubMed ID: 1319513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.